Stokes Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.08M | Buy |
38,119
+1,349
| +4% | +$250K | 1.73% | 24 |
|
|
2025
Q1 | $7.7M | Buy |
36,770
+69
| +0.2% | +$14.5K | 1.96% | 23 |
|
|
2024
Q4 | $6.52M | Buy |
36,701
+1,594
| +5% | +$283K | 1.68% | 25 |
|
|
2024
Q3 | $6.93M | Buy |
35,107
+6
| +0% | +$1.19K | 1.78% | 29 |
|
|
2024
Q2 | $6.02M | Buy |
35,101
+7,652
| +28% | +$1.31M | 1.67% | 31 |
|
|
2024
Q1 | $5M | Buy |
27,449
+324
| +1% | +$59K | 1.45% | 37 |
|
|
2023
Q4 | $4.2M | Buy |
27,125
+25,735
| +1,851% | +$3.99M | 1.33% | 37 |
|
|
2023
Q3 | $207K | Buy |
+1,390
| New | +$207K | 0.07% | 79 |
|
|
2023
Q2 | – | Sell |
-1,390
| Closed | -$222K | – | 81 |
|
|
2023
Q1 | $222K | Hold |
1,390
| – | – | 0.08% | 81 |
|
|
2022
Q4 | $225K | Buy |
+1,390
| New | +$225K | 0.08% | 84 |
|